Details for Patent: 8,946,262

Which drugs does patent 8,946,262 protect, and when does it expire?

Patent 8,946,262 protects ENTEREG and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 8,946,262

Title:	Methods of preventing and treating gastrointestinal dysfunction
Abstract:	Methods of preventing and treating gastrointestinal dysfunction, particularly postoperative ileus and post-partum ileus, in a patient undergoing surgery or other biological stress by administering 4-aryl-piperidine derivatives are disclosed.
Inventor(s):	Christ; David D (Newark, DE), Wallin; Bruce A (Haverford, PA), Garver; Deanne D (Downingtown, PA), Schmidt; William K (Davis, CA), Jackson; David (Cape Coral, FL)
Assignee:	Adolor Corporation (Lexington, MA)
Application Number:	10/999,054
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,946,262

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cubist Pharms	ENTEREG	alvimopan	CAPSULE;ORAL	021775-001	May 20, 2008		DISCN	Yes	No						A METHOD TO ACCELERATE THE TIME TO GASTROINTESTINAL RECOVERY BY ADMINISTERING ABOUT 12 MG OF ALVIMOPAN TO THE PATIENT FROM ABOUT 30 TO 60 MINUTES PRIOR TO SURGERY

International Family Members for US Patent 8,946,262

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2005055953